If your question was not answered this time, you can go directly to the source @ https://www.roto-rx.com/ where Dr. Roto will answer all your Fantasy Baseball and Football questions.
The Doctor is in...
Question #1: When I’m comparing Ben Zobrist to other players, what position do I compare him at to get a gauge for his relative worth? – East Hampton, NY
Hampton: Zobrist should be considered a 2B if you have to give him a position, considering he played the most there last year. Remember, his true value lies in his versatility.
Question #2: Now that the regular season is over, who are your MVP and CY award winners? Does Dr. Roto get an actual vote? – Jose, Ramapo, NJ
Jose: No, Dr. Roto does not get an actual vote...hopefully, he will soon. My MVP's are: Albert Pujols in the NL and Mark Teixeira in the AL. Cy Young will go to Zack Greinke in the AL and Chris Carpenter in the NL.
Question #3: Do you think that Hideki Matsui will have a full time gig in MLB next year of will he go back to Japan? – Roy, Bowling Green, MO
Roy: The only place you'll be seeing Matusi next year will be in Yankee Stadium (so long as they want him). If he is not a Yankee, he will go back to Japan.
Question #4: Did the post season problems of Joe Nathan this year affect your outlook for him for next year’s fantasy season? – Felix, Bethel, CT
Felix: Joe Nathan's struggles in the post-season have not deterred Dr. Roto from him at all. In fact, I would use it to my advantage. When his name comes up at your auction next year, you should clear your throat and say, "Nice job in the playoffs". This should drop his value 3-5 dollars in the room and you get a steal.
Question #5: Would you protect Michael Cuddyer for $12 next year? He qualifies at two spots in my league. – Salvatore, San Mateo, CA
Salvatore: I think I would. He had over 30 HR and looked sharp for most of the year. He is always undervalued to boot. Keep him.
The Doctor is out...
Follow Dr. Roto on Twitter......
Ask Dr. Roto your fantasy baseball questions.
Thursday, October 15, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment